Gainers
- Oragenics OGEN shares rose 83.4% to $0.52 during Wednesday's pre-market session. The company's market cap stands at $7.1 million.
- Pasithea Therapeutics KTTA shares moved upwards by 71.63% to $3.57. The company's market cap stands at $4.5 million.
- Mainz Biomed MYNZ stock moved upwards by 17.14% to $8.2. The market value of their outstanding shares is at $18.2 million.
- Titan Pharma TTNP shares moved upwards by 14.46% to $3.72. The company's market cap stands at $3.4 million.
- SenesTech SNES stock moved upwards by 11.88% to $3.39. The market value of their outstanding shares is at $3.5 million.
- Nanoviricides NNVC shares moved upwards by 11.75% to $1.27. The market value of their outstanding shares is at $18.2 million.
Losers
- Nuvectis Pharma NVCT stock fell 14.3% to $6.0 during Wednesday's pre-market session. The company's market cap stands at $115.9 million.
- EyePoint Pharmaceuticals EYPT stock declined by 14.18% to $6.54. The market value of their outstanding shares is at $446.3 million.
- Universe Pharmaceuticals UPC shares fell 14.01% to $0.23. The company's market cap stands at $2.0 million.
- Anitra AZTR stock fell 13.59% to $0.28. The company's market cap stands at $3.4 million.
- Evaxion Biotech EVAX shares declined by 10.4% to $2.93. The company's market cap stands at $18.3 million.
- HCW Biologics HCWB shares fell 9.95% to $0.49. The company's market cap stands at $21.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
EVAXEvaxion Biotech AS
$3.00-8.24%
EYPTEyePoint Pharmaceuticals Inc
$7.873.22%
HCWBHCW Biologics Inc
$0.4335-20.3%
KTTAPasithea Therapeutics Corp
$2.7629.0%
MYNZMainz Biomed NV
$8.0114.4%
NNVCNanoviricides Inc
$1.2812.7%
NVCTNuvectis Pharma Inc
$7.253.57%
OGENOragenics Inc
$0.28881.65%
SNESSenesTech Inc
$3.153.96%
TTNPTitan Pharmaceuticals Inc
$3.7114.2%
UPCUniverse Pharmaceuticals Inc
$0.1931-28.4%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in